MD4763B1 - Pharmaceutical composition - Google Patents
Pharmaceutical compositionInfo
- Publication number
- MD4763B1 MD4763B1 MDA20180049A MD20180049A MD4763B1 MD 4763 B1 MD4763 B1 MD 4763B1 MD A20180049 A MDA20180049 A MD A20180049A MD 20180049 A MD20180049 A MD 20180049A MD 4763 B1 MD4763 B1 MD 4763B1
- Authority
- MD
- Moldova
- Prior art keywords
- pharmaceutical composition
- levocarnitine
- consequences
- injections
- medicine
- Prior art date
Links
- 239000008194 pharmaceutical composition Substances 0.000 title abstract 2
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 abstract 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-N L-arginine Chemical compound OC(=O)[C@@H](N)CCCN=C(N)N ODKSFYDXXFIFQN-BYPYZUCNSA-N 0.000 abstract 1
- 229960003589 arginine hydrochloride Drugs 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 229960001518 levocarnitine Drugs 0.000 abstract 1
- 208000031225 myocardial ischemia Diseases 0.000 abstract 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract 1
- 239000008215 water for injection Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The present invention relates to medicine, namely to means for the treatment of ischemic heart disease and its consequences. The pharmaceutical composition contains arginine hydrochloride, levocarnitine and water for injections.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
UAU201511330U UA106905U (en) | 2015-11-17 | 2015-11-17 | Pharmaceutical formulation |
UAA201611435A UA119768C2 (en) | 2016-11-11 | 2016-11-11 | PHARMACEUTICAL COMPOSITION |
PCT/IB2016/056901 WO2017085642A1 (en) | 2015-11-17 | 2016-11-16 | Pharmaceutical composition |
Publications (3)
Publication Number | Publication Date |
---|---|
MD20180049A2 MD20180049A2 (en) | 2018-09-30 |
MD4763B1 true MD4763B1 (en) | 2021-08-31 |
MD4763C1 MD4763C1 (en) | 2022-03-31 |
Family
ID=58718454
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MDA20180049A MD4763C1 (en) | 2015-11-17 | 2016-11-16 | Pharmaceutical composition |
Country Status (2)
Country | Link |
---|---|
MD (1) | MD4763C1 (en) |
WO (1) | WO2017085642A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
UA126094C2 (en) * | 2020-07-24 | 2022-08-10 | Тов "Медичний Центр "М.Т.К." | Use of an infusion solution for treating diseases related to cerebral circulation disorders |
WO2022018707A1 (en) * | 2020-07-24 | 2022-01-27 | M.T.K. Medical Center Limited Liability Company | Infusion solution comprising arginine hydrochloride and levocarnitine for treatment and prevention of diseases in pregnant women and promotion of fetal development during pregnancy |
WO2022018705A1 (en) * | 2020-07-24 | 2022-01-27 | M.T.K. Medical Center Limited Liability Company | A pharmaceutical composition for treating cardiovascular and cerebrovascular disorders,diseases in pregnant women and improving exercise tolerance |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101336914B (en) * | 2007-07-03 | 2011-12-28 | 常州高新技术产业开发区三维工业技术研究所有限公司 | Medicine combination capable of reducing myocardial infarction area and use thereof |
CN103948581B (en) * | 2014-02-26 | 2018-05-08 | 青岛大学医学院附属医院 | Levocarnitine combines L-arginine and is preparing the application in treating diabetic retinopathy neurotrosis medicine |
-
2016
- 2016-11-16 WO PCT/IB2016/056901 patent/WO2017085642A1/en active Application Filing
- 2016-11-16 MD MDA20180049A patent/MD4763C1/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
MD20180049A2 (en) | 2018-09-30 |
MD4763C1 (en) | 2022-03-31 |
WO2017085642A1 (en) | 2017-05-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JOP20210109A1 (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
PH12018500569A1 (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
PH12017500571A1 (en) | Mono-or di-substituted indole derivatives as dengue viral replication inhibitors | |
CL2016001918A1 (en) | Heteroaryl amides as protein aggregation inhibitors | |
PH12017501272A1 (en) | Indole derivatives as dengue viral replication inhibitors | |
EA201691481A1 (en) | C5a inhibitors for the treatment of viral pneumonia | |
PH12019501018A1 (en) | Pharmaceutical composition, methods for treating and uses thereof | |
JOP20160198B1 (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
PH12016502233A1 (en) | (s)-pirlindole or its pharmaceutically acceptable salts for use in medicine | |
EA201692111A1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING DANIRYXIN FOR TREATING INFECTIOUS DISEASES | |
EA201691796A1 (en) | N-SUBSTITUTED ASYMMETRIC UREA AND THEIR APPLICATION IN MEDICINE | |
MD20180049A2 (en) | Pharmaceutical composition | |
MX2018014129A (en) | Pharmaceutical composition comprising eteplirsen. | |
PH12016502236A1 (en) | (r)-pirlindole and its pharmaceutically acceptable salts for use in medicine | |
MX2018006631A (en) | Compound for use in the prevention and treatment of neurodegenerative diseases. | |
MX2017006747A (en) | Fatty acid amides for the prevention and/or treatment of steatohepatitis. | |
TR201903234T4 (en) | Pharmaceutical solution containing dopamine for use in the treatment of Parkinson's disease. | |
MY185672A (en) | Mono-or di-substituted indole derivatives as dengue viral replication inhibitors | |
MY197383A (en) | Mono- or di-substituted indole derivatives as dengue viral replication inhibitors | |
UA106905U (en) | Pharmaceutical formulation | |
MD20150017A2 (en) | Use of Polybiolin drug in patients with liver cirrhosis | |
LV15072A (en) | Pharmaceutical composition for the prevention and treatment of diseases associated with elevated inos gene | |
BR112017003900A2 (en) | testosterone formulations and treatment methods with them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG4A | Patent for invention issued |